Vera Therapeutics (VERA) Retained Earnings (2020 - 2026)
Vera Therapeutics (VERA) reported Retained Earnings of -$156000.0 for Q1 2026, up 99.97% on a YoY basis from -$78011.9 in Q1 2025, and down 119.85% quarter-over-quarter from $786000.0 in Q4 2025.
Vera Therapeutics (VERA) Retained Earnings (2020 - 2026) Analysis & Trends
Vera Therapeutics has reported Retained Earnings for 7 years, with the latest figure at -$156000.0 in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings rose 99.97% year-over-year to -$156000.0; the trailing twelve-month figure through Mar 2026 stood at -$156000.0 (up 99.97% YoY), and the FY2025 full-year result was $786000.0, up 100.17% from the prior year.
- Retained Earnings for Q1 2026 stood at -$156000.0, down from $786000.0 in the prior quarter.
- The five-year high for Retained Earnings was $786000.0 in Q4 2025, with the low at -$669.8 million in Q3 2025.
- Historically, Retained Earnings has averaged -$225.4 million across 5 years, with a median of -$180.7 million in 2022.
- The largest YoY upside for Retained Earnings was 212.05% in 2023 against a maximum downside of 2026408.33% in 2023.
- Vera Therapeutics' Retained Earnings stood at -$224000.0 in 2022, then soared by 212.05% to $251000.0 in 2023, then sank by 183864.94% to -$461.2 million in 2024, then soared by 100.17% to $786000.0 in 2025, then sank by 119.85% to -$156000.0 in 2026.
- The last three Retained Earnings figures came in at -$156000.0 (Q1 2026), $786000.0 (Q4 2025), and -$669.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Vera Therapeutics | 2.51 Bn | 1.91 Bn | - | -156,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -156,000.00 |
| Dec 31, 2025 | 786,000.00 |
| Sep 30, 2025 | -669.80 Mn |
| Jun 30, 2025 | -589.48 Mn |
| Mar 31, 2025 | -512.90 Mn |
| Dec 31, 2024 | -461.25 Mn |
| Sep 30, 2024 | -417.83 Mn |
| Jun 30, 2024 | -450,000.00 |
| Mar 31, 2024 | -337.50 Mn |
| Dec 31, 2023 | 251,000.00 |
| Sep 30, 2023 | -75,000.00 |
| Jun 30, 2023 | -263.30 Mn |
| Mar 31, 2023 | -243.18 Mn |
| Dec 31, 2022 | -224,000.00 |
| Sep 30, 2022 | -180.70 Mn |
| Jun 30, 2022 | -155.99 Mn |
| Mar 31, 2022 | -12,000.00 |
| Dec 31, 2021 | -124.06 Mn |
| Sep 30, 2021 | -107.21 Mn |
| Jun 30, 2021 | -99.60 Mn |